WASHINGTON, APRIL 5: The manufacturer of eye drops recently linked to deaths and injuries lacked measures to assure sterility at its factory in India, according to U.S. health inspectors. Food and Drug Administration officials uncovered about a dozen problems with how Global Pharma Healthcare made and tested its eye drops during an inspection from late […]Continue Reading
